ZNF397OS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.935100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.737800E-01
Normal-vs-Stage2
1.972770E-01
Normal-vs-Stage3
1.305180E-01
Normal-vs-Stage4
1.441550E-01
Stage1-vs-Stage2
2.982200E-01
Stage1-vs-Stage3
1.145580E-01
Stage1-vs-Stage4
5.346000E-01
Stage2-vs-Stage3
1.17972298596669E-12
Stage2-vs-Stage4
5.592600E-01
Stage3-vs-Stage4
1.318780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.095100E-03
Normal-vs-AfricanAmerican
2.064800E-01
Normal-vs-Asian
1.395240E-01
Caucasian-vs-AfricanAmerican
5.254200E-01
Caucasian-vs-Asian
3.163500E-02
AfricanAmerican-vs-Asian
8.153800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.181700E-03
Normal-vs-Female
7.875700E-03
Male-vs-Female
4.191000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.597600E-01
Normal-vs-Age(41-60Yrs)
1.222440E-02
Normal-vs-Age(61-80Yrs)
1.160930E-03
Normal-vs-Age(81-100Yrs)
1.919650E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.960200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.782000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.647600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.333600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.613640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.398000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.848790E-01
Normal-vs-Daily Drinker
2.073700E-02
Normal-vs-Weekly Drinker
1.778990E-01
Normal-vs-Occasional Drinker
1.914420E-01
Normal-vs-Social Drinker
6.597900E-02
Non Drinker-vs-Daily Drinker
9.258000E-01
Non Drinker-vs-Weekly Drinker
8.050200E-01
Non Drinker-vs-Occasional Drinker
6.744100E-02
Non Drinker-vs-Social Drinker
3.126400E-02
Daily Drinker-vs-Weekly Drinker
7.844600E-01
Daily Drinker-vs-Occasional Drinker
1.146190E-01
Daily Drinker-vs-Social Drinker
1.499550E-01
Weekly Drinker-vs-Occasional Drinker
5.278000E-02
Weekly Drinker-vs-Social Drinker
4.118400E-02
Occasional Drinker-vs-Social Drinker
7.809800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.429780E-01
Normal-vs-Grade 2
7.841800E-02
Normal-vs-Grade 3
2.088500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.649900E-02
Grade 1-vs-Grade 3
1.052820E-01
Grade 1-vs-Grade 4
1.429780E-01
Grade 2-vs-Grade 3
6.638600E-01
Grade 2-vs-Grade 4
7.841800E-02
Grade 3-vs-Grade 4
2.088500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.808770E-01
Normal-vs-NonDiabetic
8.598300E-03
Diabetic-vs-NonDiabetic
9.563600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.636800E-01
Normal-vs-NoPancreatitis
4.960000E-03
Pancreatitis-vs-NoPancreatitis
4.795600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.529500E-02
Normal-vs-N1
1.964370E-01
N0-vs-N1
2.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.002600E-01
Normal-vs-TP53-NonMutant
1.261980E-01
TP53-Mutant-vs-TP53-NonMutant
8.10830000000928E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
